Loading page…
Search companies, filings, portfolio…
⌘K
Sign in
Sign up
SP
Symbiotec Pharmalab Limited
NSE:
SYMBIOTEC
BSE:
SYMBIOTEC
Healthcare
Pharmaceuticals & Biotechnology
₹1,198.0
+1.81%
1 Oct close
Mkt cap
₹7,703 Cr
Watch
Alert
Compare
Overview
Chart
Peers
Profit & loss
Balance sheet
Cash flow
Ratios
Shareholding
F&O
Fund holders
Documents
Events
Announcements
Notes
Annual
Quarterly
Consolidated
Standalone
Consolidated figures · ₹ crore
Quarterly results
₹ Cr
Jun 2026
Revenue
218
COGS
76
Gross profit
143
Operating expenses
+
97
Operating profit (EBITDA)
+
45
OPM %
20.7%
Depreciation
22
Interest
6
Other income
+
0
Profit before tax
18
Tax
3
Tax %
19.8%
PAT
14
PAT margin %
6.5%
EPS (₹)
2.2
Results filing
Results filing for Jun 2026